Evropska unija -
slovenščina -
EMA (European Medicines Agency)
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - Človekove normalno imunoglobulina - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - imunski sera in imunoglobulini, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
tavlesse
instituto grifols s.a. - fostamatinib disodium - trombocitopenija - drugi sistemski hemostatics - tavlesse je indiciran za zdravljenje kronične imunska trombocitopenija (itp) pri odraslih bolnikih, ki so utrjene za druge oblike zdravljenja.
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
veraseal
instituto grifols, s.a. - humani fibrinogen, humani trombin - hemostaz, kirurški - antihemoragije - podporno zdravljenje pri odraslih, kjer standardne kirurške tehnike so dovolj:za izboljšanje haemostasisas šivanje podporo v vaskularna kirurgija.
